[1] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3): 209-249. [2] Shrestha AD, Vedsted P, Kallestrup P, et al.Prevalence and incidence of oral cancer in low-and middle-income countries: a scoping review[J]. Eur J Cancer Care (Engl), 2020, 29(2): e13207. [3] Liu TPJ, Fisher BM, Chua B, et al.Survival outcomes following modern multidisciplinary management of oral squamous cell carcinoma in Australia[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2021, 131(1): 92-98. [4] Muller S, Tilakaratne WM.Update from the 5th edition of the World Health Organization classification of head and neck tumors: tumours of the oral cavity and mobile tongue[J]. Head Neck Pathol,2022,16(1): 54-62. [5] 叶春林, Khudoyberdiev Ilkhomjon, 陈颖,等. 菟丝子多糖的抗氧化活性和抑制肿瘤细胞增殖的研究[J]. 河南工业大学学报(自然科学版), 2020, 41(5): 73-78. [6] 胡丹,丁同同,李江,等. 雷公藤提取物中主要物质基础及其抗肿瘤活性研究[J]. 广西植物, 2022, 42(9): 1514-1521. [7] 李梦, 孙晋虎, 孟箭.青蒿琥酯对人舌鳞癌CAL27细胞的体外抑制作用[J].上海口腔医学, 2022, 31(1): 32-37. [8] 杨月伟, 张培玉. 斑蝥的药用研究及其开发[J].资源开发与市场1999,15(6): 326-327. [9] Ren Y, Kinghorn A.Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives[J]. Bioorg Med Chem, 2021, 32: 116012. [10] Pang J, Huang F, Zhang Y, et al.Sodium cantharidate induces apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5-p53 axis[J]. Toxicol Appl Pharmacol,2021,430: 115726. [11] 王玲, 樊红莲, 王西勇. 斑蝥酸钠诱导非小细胞肺癌H1975细胞凋亡的作用及机制研究[J]. 中药药理与临床, 2022, 38(1): 47-51. [12] 徐文会, 赵浩亮, 魏文贵, 等. 斑蝥酸钠对人肝癌细胞HepG2的增殖作用及血管内皮生长因子表达的影响[J]. 中国医疗前沿, 2012, 7(4): 4-5. [13] Wang G, Dong J, Deng L.Overview of cantharidin and its analogues[J]. Curr Med Chem, 2018, 25(17): 2034-2044. [14] 黄富豪, 徐廉松, 牛雯雯, 等. 斑蝥酸钠对肝癌细胞侵袭、迁移影响的实验研究[J]. 中药药理与临床, 2022, 38(2): 58-64. [15] Wajant H.The Fas signaling pathway: more than a paradigm[J]. Science, 2002, 296(5573): 1635-1636. [16] Denicourt C, Dowdy SF.Targeting apoptotic pathways in cancer cells[J]. Science, 2004, 305(5689): 1411-1413. [17] Martinou JC, Youle RJ.Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics[J]. Dev Cell, 2011, 21(1): 92-101. [18] Shimizu S, Tsujimoto Y.Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity[J]. Proc Natl Acad Sci USA, 2000, 97(2): 577-582. [19] Li HH, Su JH, Chiu CC, et al.Proteomic investigation of the sinulariolide-treated melanoma cells A375: effects on the cell apoptosis through mitochondrial-related pathway and activation of caspase cascade[J]. Mar Drugs, 2013, 11(7): 2625-2642. [20] Green DR, Reed JC.Mitochondria and apoptosis[J]. Science, 1998, 281(5381): 1309-1312. [21] Nicholson DW, Thornberry NA.Life and death decisions[J]. Science, 2003, 299(5604): 214-215. [22] Zhang J, Cao M, Dong J, et al.ABRO 1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53[J]. Nat Commun, 2014, 5: 5059. [23] Nguyen TA, Menendez D, Resnick MA, et al.Mutant TP53 posttranslational modifications: challenges and opportunities[J]. Hum Mutat, 2014, 35(6): 738-755. [24] Xiao YT, Yan WH, Lu L, et al.p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death[J]. Cell Cycle, 2015, 14(10): 1548-1558. [25] Lambert PF, Kashanchi F, Radonovich MF, et al.Phosphorylation of p53 serine 15 increases interaction with CBP[J]. J Biol Chem, 1998, 273(49): 33048-33053. [26] Oda K, Arakawa H, Tanaka T, et al.p53AIP1,a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53[J]. Cell, 2000, 102(6): 849-862. [27] Matsuda K, Yoshida K, Taya Y, et al.p53AIP1 regulates the mitochondrial apoptotic pathway[J]. Cancer Res, 2002, 62(10): 2883-2889. |